STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its participation in two major investor conferences in June 2025. The company will present at the Jefferies 2025 Global Healthcare Conference on June 5 at 12:50 p.m. ET and participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 8:00 a.m. ET. Both presentations will be available via live webcast through Kiniksa's website in the Investors & Media section, with replays accessible within 48 hours after each event.

[]
Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.66% News Effect

On the day this news was published, KNSA gained 0.66%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June:

  • Jefferies 2025 Global Healthcare Conference on Thursday, June 5 at 12:50 p.m. Eastern Time
  • Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10 at 8:00 a.m. Eastern Time – Fireside Chat

A live webcast of Kiniksa’s presentations will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the events will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ®

Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com


FAQ

When is Kiniksa Pharmaceuticals (KNSA) presenting at the Jefferies Healthcare Conference 2025?

Kiniksa Pharmaceuticals will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 12:50 p.m. Eastern Time.

What time is KNSA's presentation at the Goldman Sachs Healthcare Conference 2025?

Kiniksa Pharmaceuticals will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Tuesday, June 10, 2025, at 8:00 a.m. Eastern Time.

How can I access Kiniksa Pharmaceuticals' investor conference presentations?

The presentations can be accessed through live webcasts in the Investors & Media section of Kiniksa's website at www.kiniksa.com. Replays will be available within 48 hours after each event.

Which investor conferences is KNSA attending in June 2025?

KNSA is attending two conferences: the Jefferies Global Healthcare Conference on June 5 and the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025.
Kiniksa Pharmaceuticals International, plc

NASDAQ:KNSA

KNSA Rankings

KNSA Latest News

KNSA Latest SEC Filings

KNSA Stock Data

3.11B
43.64M
3.74%
92.97%
3.65%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United Kingdom
LONDON